TFRC and cardiovascular disorder: Moreover, inhibition of USP7 activated p53 and decreased TfR1, and then attenuates ferroptosis and protects the heart from myocardial I/R injury (Tang et al., 2021), suggesting that inhibition of USP7 may be a potential therapy for cardiovascular disease.